Definium Therapeutics, Inc. (DFTX): Shareholders' Equity
$332.33M
As of 2025-12-31
$918.68M
As of 2026-06-30
+30.1%
3-year compound annual growth
+34.4%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $332.33M | +37.6% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $241.45M | +209.0% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $78.13M | -48.2% | 2025-03-06, Balance as of period end |
| 2022-12-31 | $150.92M | -0.5% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $151.66M | +99.9% | 2023-03-09, Balance as of period end |
| 2020-12-31 | $75.87M | n/m | 2022-03-28, Balance as of period end |
| 2019-12-31 | $4.78M | n/a | 2022-03-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | 2025-12-31 | $332.33M | +37.6% |
| Jushi Holdings Inc. (JUSH) | 2025-12-31 | -$115.34M | n/m |
| Glass House Brands Inc. (GLAS) | 2025-12-31 | $73.94M | -36.4% |
| USANA Health Sciences Inc (USNA) | 2026-01-03 | $533.10M | +0.2% |
| Ascend Wellness Holdings, Inc. (AAWH) | 2025-12-31 | -$46.62M | n/m |
| Marimed Inc. (MRMD) | 2025-12-31 | $50.01M | -14.6% |
| Cronos Group Inc. (CRON) | 2025-12-31 | $1.14B | +2.9% |
| Cresco Labs Inc. (CRLBF) | 2025-12-31 | $340.45M | -28.3% |
| Natural Alternatives International Inc (NAII) | 2026-06-30 | $49.96M | -27.0% |
Compare DFTX, JUSH, GLAS, USNA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗